SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Physician Fights Insurer to Cover Her Baby's Brain Cancer Treatment

2.

A small rise in cancer was observed following the 1986 Chernobyl accident.

3.

First-Line Combination for Bladder Cancer Not Eligible for Cisplatin Just Misses Positive Outcome.

4.

New research uncovers link between cancer pathway and blood-retina barrier function

5.

Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot